Delivery Order SPE2DR25D7066-SPE2DR26F7ZMR
- Not listed
- The Defense Logistics Agency awarded a $1,073.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Fluocinolone 0.01% body oil (118.28 mL) on November 10, 2025, with an ultimate completion date of November 12, 2025. This non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the Defense...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,816.21 on December 15, 2025, for Fluocinolone 0.01% Cream in 60-gram units, with completion scheduled for December 16, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This federal contract award is for the delivery of Fluocinolone 0.01% Scalp Oil, 118.28 ML to the Defense Logistics Agency (DLA). The contract, valued at $1,991.27, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is a firm fixed price delivery order, with a completion date of September 28, 2023. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp serves as a...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,860.56 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, for the supply of Fluocinolone 0.05% Calibrated Reference Material. This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which is valued at $999,999,999.00 and extends through...
- The Defense Logistics Agency awarded a $85,280 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 118.28 milliliters of 0.01% fluocinolone body oil. The place of performance is Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. The order is to be completed between July 13-14, 2023. No additional details were provided regarding the original solicitation or whether this award is associated with any particular contract vehicles or programs at DLA....
- Defense Logistics Agency awarded a delivery order against an unspecified contract vehicle to Amerisourcebergen Drug Corp for $228 to supply 118.28ml bottles of fluocinolone 0.01% body oil. Performance will occur in Conshohocken, Pennsylvania with all requirements to be completed by October 19, 2023. As no set-aside designation was used, this was an unrestricted award. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distributor, indicating...
- The Defense Logistics Agency awarded a delivery order valued at $3,129.00 to AmerisourceBergen Drug Corp for the supply of Fluocinonide 0.05% Cream in 15-gram units. This competitively awarded, non-set-aside contract was executed on July 21, 2025, with an ultimate completion date of July 22, 2025, utilizing firm fixed pricing. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major...
- <p>Defense Logistics Agency awarded a $457 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for FLUOCINOLONE 0.01% BODY OIL 118.28ML. Performance will occur in Conshohocken, Pennsylvania, with an anticipated completion date of October 12, 2023. No set-aside designation was applied to this order under the parent Amerisourcebergen contract vehicle.</p>
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,251.38, is for the procurement of Fluocinolone 0.01% Cream, a medical product used in various healthcare applications. The contract is a Firm Fixed Price type, with an ultimate completion date of January 18, 2024. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- The Defense Logistics Agency awarded a $49,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561436989 FLUOCINOLONE 0.01% SOLUTION 60ML. The prime contractor, a subsidiary of Amerisourcebergen Corporation, will deliver the pharmaceutical product to a location in Conshohocken, Pennsylvania within the period of performance from July 7-10, 2023. The order was placed under an existing DLA contract vehicle to support the agency's medical supply needs. No set aside...
- SPE2DR25D7066Indefinite Delivery Contract
- SPE2DR25D7066-SPE2DR26F7ZMRDelivery Order
The Defense Logistics Agency awarded a $1,267.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Fluocinolone 0.01% Scalp Oil (118.28ML) on December 16, 2025, with an ultimate completion date of December 17, 2025. The contract, which carries no set-aside designation, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant federal contract portfolio with the Defense Logistics Agency and its Medical Supply Chain, serving critical customers including the Defense Health Agency and U.S. Coast Guard. The company's demonstrated capability to meet federal procurement requirements through open competition is evidenced by its consistent receipt of competitively awarded, non-set-aside delivery orders with firm fixed pricing across diverse pharmaceutical products and therapeutic domains, ranging from routine medical supplies to specialty medications supporting military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 12/15/25 |